Northwick Park Hospital

London SE5 9RS

0 studies enrolling now · 5 studies all time

What they study most

COVID-19, Dermatitis, Atopic, Lymphoma, Thyroid Eye Disease

Studies at this site

• A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) — Stopped early
• A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED) — Completed
• A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma — Completed
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment — Completed
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) — Completed